PMID: 3767066Oct 1, 1986Paper

Angina pectoris and acute myocardial infarction due to "slow-flow phenomenon" in nonatherosclerotic coronary arteries: a case report

Angiology
J Z Przybojewski, P H Becker

Abstract

A 51 year-old White woman with angina pectoris and nonatheromatous coronary artery disease is presented. Cardiac catheterization demonstrated a "slow-flow phenomenon" in the left coronary artery accompanied by severe angina pectoris and anterolateral ST-segment elevation and culminating in an acute nontransmural myocardial infarction. At repeat coronary arteriography, ergonovine maleate provocation proved negative. This patient is unique, since the previously documented 6 cases with this coronary cineangiographic response did not exhibit angina pectoris or ECG evidence of myocardial ischemia during the "slow-flow phenomenon," and none was complicated by an acute myocardial infarction. Various aspects of the pathophysiology of angina pectoris in this patient, including the recently described "reduced vasodilator reserve" concept, are briefly outlined.

References

Feb 25, 1978·Lancet·D Robertson, J A Oates
Apr 1, 1978·The American Journal of Cardiology·F A HeuplerW C Sheldon
Apr 1, 1978·The American Journal of Cardiology·R H Helfant
Jan 1, 1985·Catheterization and Cardiovascular Diagnosis·J Z Przybojewski
Feb 1, 1985·International Journal of Cardiology·R O Cannon
Mar 1, 1983·Journal of the American College of Cardiology·R Gorlin
Dec 1, 1983·Journal of the American College of Cardiology
Jun 1, 1983·Journal of the American College of Cardiology·R O CannonS E Epstein
Jun 1, 1983·Journal of the American College of Cardiology·L P Temkin, F I Marcus
Aug 1, 1980·The American Journal of Cardiology·A Fester
Mar 26, 1981·The New England Journal of Medicine·D MillerP Théroux

❮ Previous
Next ❯

Citations

Jun 1, 1991·Catheterization and Cardiovascular Diagnosis·J Van LierdeJ Piessens
Oct 1, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·C Camaro, W R M Aengevaeren
Jul 1, 1996·Journal of the American College of Cardiology·J C BurnsT Kawasaki
Mar 16, 2001·The American Journal of Cardiology·N KurtogluI Dindar
Dec 19, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Hatice SelcukOmac Tüfekcioglu
Jul 27, 2005·International Heart Journal·Nurzen SezginOsman Karakaya
Jan 9, 2004·Japanese Heart Journal·V Gökhan CinOben Döven
Apr 26, 2006·The Tohoku Journal of Experimental Medicine·Fatma YigitHaldun Muderrisoglu
Aug 13, 2011·The Tohoku Journal of Experimental Medicine·Osman KarakayaIrfan Barutcu
Dec 18, 2013·Cardiovascular Journal of Africa·Veysel Kenan CelikHüseyin Aydin
Apr 9, 2005·Clinical Cardiology·Mustafa GökçeMehmet Küçükosmanoğlu
Jan 18, 2006·Medical Hypotheses·Jian-Jun LiXue-Wen Qin
Nov 18, 2005·Medical Hypotheses·Jian-Jun LiBing-Qi Wei
Nov 9, 2005·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Edgardo Zavala-AlarconRajul Patel
Aug 21, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jian-Jun LiJie Li
Jul 27, 2007·Angiology·Muhsin TurkmenYelda Basaran
May 13, 2017·Journal of Atrial Fibrillation·Murat SucuEsra Polat
Feb 11, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Muhsin TürkmenIrfan Barutcu
Feb 2, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Beau M HawkinsEliot Schechter
Jan 1, 2009·Clinical Medicine. Cardiology·Selma TiryakiogluTahsin Bozat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.